Rescue experiments aimed at establishing the regulatory axis of ALKBH5/IGF2BP2/HMMR in NSCLC demonstrated that transfection of the ALKBH5 plasmid into IGF2BP2-overexpressing cells restored HMMR levels (Figure 7I). The gene discussed is HMMR; the disease is non-small cell lung carcinoma.